Below are the top 10 U.S.-listed Chinese stocks with highest upside potential, UPDATED TODAY before 4:30 AM ET, based on the difference between current price and Wall Street analysts' average target price.
China Education Alliance, Inc. (NYSE:CEU) has the 1st highest upside potential in this segment of the market. Its upside is 240.0%. Its consensus target price is $8.50 based on the average of all estimates. NIVS IntelliMedia Technology Group Inc (NYSE:NIV) has the 2nd highest upside potential in this segment of the market. Its upside is 222.6%. Its consensus target price is $7.00 based on the average of all estimates. SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) has the 3rd highest upside potential in this segment of the market. Its upside is 200.2%. Its consensus target price is $13.00 based on the average of all estimates. NF Energy Saving Corp (NASDAQ:NFEC) has the 4th highest upside potential in this segment of the market. Its upside is 172.9%. Its consensus target price is $12.50 based on the average of all estimates. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) has the 5th highest upside potential in this segment of the market. Its upside is 156.4%. Its consensus target price is $7.00 based on the average of all estimates.
China Ritar Power Corp. (NASDAQ:CRTP) has the 6th highest upside potential in this segment of the market. Its upside is 150.6%. Its consensus target price is $6.67 based on the average of all estimates. Xinyuan Real Estate Co., Ltd. (ADR) (NYSE:XIN) has the 7th highest upside potential in this segment of the market. Its upside is 143.3%. Its consensus target price is $6.67 based on the average of all estimates. ZST Digital Networks Inc (NASDAQ:ZSTN) has the 8th highest upside potential in this segment of the market. Its upside is 141.7%. Its consensus target price is $16.00 based on the average of all estimates. Shiner International, Inc. (NASDAQ:BEST) has the 9th highest upside potential in this segment of the market. Its upside is 125.6%. Its consensus target price is $3.00 based on the average of all estimates. China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP) has the 10th highest upside potential in this segment of the market. Its upside is 125.4%. Its consensus target price is $8.25 based on the average of all estimates.
Negocioenlinea
tdp2664
China Analyst
Top 10 U.S.-Listed Chinese Stocks with Highest Upside: CEU, NIV, SPU, NFEC, BSPM, CRTP, XIN, ZSTN, BEST, NKBP (Jan 10, 2011)
No comments:
Post a Comment